(Q30872798)

25 September 2017

Breast cancer liver metastases: US-guided percutaneous radiofrequency ablation--intermediate and long-term survival rates (English)

1 reference

25 September 2017

1 reference

Maria Franca Meloni

1

1 reference

25 September 2017

Anita Andreano

2

1 reference

25 September 2017

Paul F Laeseke

3

1 reference

25 September 2017

Tito Livraghi

4

1 reference

25 September 2017

Sandro Sironi

5

1 reference

25 September 2017

Fred T Lee

6

1 reference

25 September 2017

language of work or name

English

0 references

publication date

25 August 2009

1 reference

25 September 2017

1 reference

25 September 2017

253

1 reference

25 September 2017

3

1 reference

25 September 2017

861-869

1 reference

Resection versus no intervention or other surgical interventions for colorectal cancer liver metastases

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Radiofrequency ablation of primary and metastatic liver tumors: a critical review of the literature

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

21 June 2018

Cancer statistics, 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis: Is resection still the treatment of choice?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Radiofrequency ablation in the management of liver metastases from breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Actual role of radiofrequency ablation of liver metastases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Estimates of the cancer incidence and mortality in Europe in 2006.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Focal tumor ablation: a new era in cancer therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Solitary colorectal liver metastasis: resection determines outcome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Radiofrequency ablation of liver tumors: the role of microbubble ultrasound contrast agents.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Outcomes after surgical treatment of colorectal cancer liver metastases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Image guided tumour ablation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Staging and current treatment of hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Percutaneous radiofrequency ablation of hepatic colorectal metastases: technique, indications, results, and new promises.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Breast cancer metastases in liver: laser-induced interstitial thermotherapy--local tumor control rate and survival data

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Clinical outcome of breast cancer patients with liver metastases alone in the anthracycline-taxane era: a retrospective analysis of two prospective, randomised metastatic breast cancer trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Cost-effectiveness of hepatic metastasectomy in patients with metastatic colorectal carcinoma: a state-transition Monte Carlo decision analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Surgical management of hepatic metastases from colorectal malignancies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Interval hepatic resection of colorectal metastases improves patient selection

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

The role of chemotherapy for metastatic breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Breast Liver Metastases – Incidence, Diagnosis and Outcome

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Liver resection for breast cancer metastasis: does it improve survival?

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

A place for radiofrequency ablation in the treatment of resectable colorectal liver metastases?

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Clinical course of breast cancer patients with metastases limited to the liver treated with chemotherapy

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Is liver resection justified for patients with hepatic metastases from breast cancer?

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Liver metastases from breast cancer: the role of surgical treatment.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Therapeutic response assessment of percutaneous radiofrequency ablation for hepatocellular carcinoma: utility of contrast-enhanced agent detection imaging.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Radiofrequency ablation of colorectal liver metastases.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Open-configuration MR-guided microwave thermocoagulation therapy for metastatic liver tumors from breast cancer

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach".

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4067493

Radiofrequency ablation of liver metastases from breast cancer: results in 14 patients

25 November 2018

1 reference

12 December 2020

Hepatectomy for metastases from breast cancer offers the survival benefit similar to that in hepatic metastases from colorectal cancer

1 reference

12 December 2020

Surgical treatment of hepatic metastases from breast cancer

1 reference

12 December 2020

Comparison of contrast enhanced ultrasound and contrast enhanced CT or MRI in monitoring percutaneous thermal ablation procedure in patients with hepatocellular carcinoma: a multi-center study in China

1 reference

12 December 2020

Is radiofrequency ablation the treatment of choice for patients with small hepatocellular carcinoma?

1 reference

12 December 2020

Liver metastases from breast cancer: long-term survival after curative resection

1 reference

12 December 2020

Clinical course of breast cancer patients with liver metastases

1 reference

12 December 2020

Percutaneous RF interstitial thermal ablation in the treatment of hepatic cancer

1 reference

12 December 2020

Metastatic colorectal carcinoma: cost-effectiveness of percutaneous radiofrequency ablation versus that of hepatic resection

1 reference

12 December 2020

Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of indications for resection. Registry of Hepatic Metastases

1 reference

12 December 2020

Guidance and monitoring of radiofrequency liver tumor ablation with contrast-enhanced ultrasound

1 reference

12 December 2020

The regional treatment of liver metastases from breast cancer

1 reference

12 December 2020

Hepatic Resection for Liver Metastases as Part of the “Oncosurgical” Treatment of Metastatic Breast Cancer

1 reference

12 December 2020

Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast

1 reference

12 December 2020

Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients

1 reference

12 December 2020

Liver metastases of breast cancer: results of liver resection

1 reference

12 December 2020

Improved anti-tumor response rate with decreased cardiotoxicity of non-pegylated liposomal doxorubicin compared with conventional doxorubicin in first-line treatment of metastatic breast cancer in patients who had received prior adjuvant doxorubicin

1 reference

12 December 2020

Long-term survival after an aggressive surgical approach in patients with breast cancer hepatic metastases

1 reference

12 December 2020

[Hepatic resection for breast cancer metastases: results and prognosis (65 cases)]

1 reference

12 December 2020

10.1148/RADIOL.2533081968

Identifiers

DOI

1 reference

25 September 2017

1 reference

25 September 2017

PubMed publication ID

19709994

1 reference